Topic Review
Omega-3 Fatty Acids in Arterial Hypertension
Omega-3 polyunsaturated fatty acids (ω-3 PUFAs), including alpha-linolenic acid (ALA) and its derivatives eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), are “essential” fatty acids mainly obtained from diet sources comprising plant oils, marine blue fish, and commercially available fish oil supplements.
  • 259
  • 17 Aug 2023
Topic Review
LAs in Pain, Inflammation, and Other Clinical Conditions
The use of low-dose local anesthetics in low concentrations for therapeutic, non-anesthetic purposes, known as neural therapy, has significantly transformed patient care by providing rapid, effective, long-lasting and safe relief of pain, inflammation and other clinical conditions while minimizing recovery time. 
  • 258
  • 05 Dec 2023
Topic Review
IL-33/IL-31 Axis in Autoimmune Disorders
Several allergic and immunologic diseases including asthma, food allergy (FA), chronic spontaneous urticaria (CSU), atopic dermatitis (AD), systemic lupus erythematosus (SLE), systemic sclerosis (SSc), rheumatoid arthritis (RA), and Behçet’s disease (BD) are characterized by the involvement of Th2 immunity. Several mediators lead to immunoglobulin (Ig)E production, thus including key cytokines such as interleukin (IL)-4, IL-5, and IL-13. Among them, IL-31 and IL-33 have been recently studied as novel biomarkers and future therapeutic targets for allergic and immunological disorders. IL-31 is a proinflammatory cytokine—it regulates cell proliferation and is involved in tissue remodeling. IL-33, acting through its receptor suppression of tumorigenity (ST2L), is an alarmin cytokine from the IL-1 family, whose expression is mediated by tissue damage. The latter has a pleiotropic effect, as it may modulate specific and innate immune cells functions.
  • 257
  • 01 Aug 2023
Topic Review
Inflammation in Obesity
Obesity, as a part of metabolic syndrome, represents the leading factor for disability, and is correlated with higher inflammation status, morbidity, and mortality. Biomarkers of high-level chronic inflammation are recognized as important predictors of pro-inflammatory disease. Besides the well-known pro-inflammatory cytokines, such as WBCs (white blood cells), IL-1 (interleukin-1), IL-6 (interleukin-6), TNF-alpha (tumor necrosis factor-alpha), and hsCRP (high-sensitivity C-reactive protein), as well as anti-inflammatory markers, such as adiponectin and systemic inflammation, can be determined by a variety of blood tests as a largely available and inexpensive inflammatory biomarker tool.
  • 248
  • 13 Jun 2023
Topic Review
Implications of Pituitary Tumorigenesis for Management
Pituitary neuroendocrine tumors (PitNETs), the third most common intracranial tumor, are mostly benign. However, some of them may display a more aggressive behavior, invading into the surrounding structures. While they may rarely metastasize, they may resist different treatment modalities. Several major advances in molecular biology led to the discovery of the possible mechanisms involved in pituitary tumorigenesis with a possible therapeutic implication. The mutations in the different proteins involved in the Gsa/protein kinase A/c AMP signaling pathway are well-known and are responsible for many PitNETS, such as somatotropinomas and, in the context of syndromes, as the McCune–Albright syndrome, Carney complex, familiar isolated pituitary adenoma (FIPA), and X-linked acrogigantism (XLAG). The other pathways involved are the MAPK/ERK, PI3K/Akt, Wnt, and the most studied HIPPO pathways. Moreover, the mutations in several other tumor suppressor genes, such as menin and CDKN1B, are responsible for the MEN1 and MEN4 syndromes and succinate dehydrogenase (SDHx) in the context of the 3PAs syndrome. 
  • 247
  • 26 May 2023
Topic Review
Pulvermacher's Chain
The Pulvermacher chain, or in full as it was sold the Pulvermacher hydro-electric chain, was a type of voltaic battery sold in the second half of the 19th century for medical applications. Its chief market was amongst the numerous quack practitioners who were taking advantage of the popularity of the relatively new treatment of electrotherapy, or "electrification" as it was then known. Its unique selling point was its construction of numerous linked cells, rendering it mechanically flexible. A variant intended to be worn wrapped on parts of the body for long periods was known as Pulvermacher's galvanic chain or electric belt. The Pulvermacher Company attracted a great deal of antagonism from the medical community due to their use of the names of well-known physicians in their advertising without permission. The nature of their business; in selling to charlatans and promoting quack practices also made them unpopular with the medical community. Despite this, the Pulvermacher chain was widely reported as a useful source of electricity for medical and scientific purposes, even amongst the most vocal critics of the Pulvermacher Company.
  • 245
  • 18 Oct 2022
Topic Review
Sodium–Glucose Cotransporter 2 and Kidney Function
Sodium–glucose cotransporter 2 inhibitors (SGLT2i) are a relatively novel class of molecules named gliflozines that were originally designed to control glycemia, but over and above their effect on the glycemic metabolism, they unexpectedly improved the management of clinical conditions involving the function of the heart and kidneys. Importantly, the benefits of SGLT2i go beyond guideline-directed medical therapy, in that the drug’s metabolic effects on the kidneys and heart ameliorate the entire cardio–circulatory outcome.
  • 243
  • 20 Jun 2023
Topic Review
Status Dynamic Psychotherapy
Status dynamic psychotherapy (SDT) is an approach to psychotherapy that was created by Peter G. Ossorio at the University of Colorado in the late 1960s as part of a larger system known as "descriptive psychology". Its distinguishing characteristic is that it does not focus on the factors traditionally targeted by psychotherapy such as the client’s behaviors, cognitions, insight into unconscious factors, and patterns of interaction with significant others. Instead, it focuses on bringing about changes in clients’ statuses; i.e., the positions that they occupy in relation to everything in their worlds, including themselves and aspects of themselves. Proponents of SDT maintain:
  • 240
  • 08 Nov 2022
Topic Review
Sarcopenia and Diabetes
Sarcopenia is an age-related clinical complaint characterized by the progressive deterioration of skeletal muscle mass and strength over time. Type 2 diabetes (T2D) is associated with faster and more relevant skeletal muscle impairment. Both conditions influence each other, leading to negative consequences on glycemic control, cardiovascular risk, general health status, risk of falls, frailty, overall quality of life, and mortality.
  • 237
  • 12 Jan 2024
Topic Review
Therapeutic Strategies for Diabetic Kidney Disease (DKD)
The key approach to reduce diabetic kidney disease (DKD)-mediated end-stage renal disease (ESRD)  is to prevent and delay the renal function decline, as once a fall in renal function occurs, it is difficult to regain, apart from when normoglycemic conditions are implemented for a long time, such as following pancreas transplantation. In parallel to lifestyle, glycemic and blood pressure control, all cornerstones for the prevention of DKD, the researchers outline five major treatment “pillars” that possess major renal protective properties
  • 233
  • 18 May 2023
  • Page
  • of
  • 48
Video Production Service